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Abstract: The monolayer-forming, human choriocarcinoma cell line, BeWo, was used to study 
the mechanisms of monocarboxylic acid transport across the human trophoblast. Benzoic acid, 
acetic acid, and lactic acid were used as markers for monocarboxylic acid carrier-mediated 
transport.  The uptake of benzoic acid by BeWo cells was saturable (Kt = 0.6 ± 0.3 mM) at 
higher concentrations and significantly inhibited by typical metabolic inhibitors, sodium azide 
and 2,4-dinitrophenol.   A selection of different monocarboxylic acids, including a natural 
substrate lactic acid,  also substantially inhibited the uptake of benzoic acid and acetic acid by 
BeWo cells, whereas dicarboxylic acids did not affect the uptake of either marker. 
Monocarboxylic acid uptake was pH-dependent and inhibited by carbonylcyanide p-
trifluoromethoxyphenylhydrazone (FCCP), a protonophore. Kinetic analysis using Lineweaver-
Burk plots revealed that monocarboxylic acids competitively inhibited the uptake of benzoic, 
lactic, and acetic acid by BeWo cells.  In transport experiments, the permeation of benzoic acid 
from apical-to-basolateral side was greater than the permeation from the basolateral-to-apical 
side, and the transport of benzoic acid from apical-to-basolateral side was inhibited by 
monocarboxylic acids. The findings obtained in the present study confirm the existence of an 
asymmetric, carrier-mediated transport system for monocarboxylic acids across the BeWo cell, 
a representative of the human trophoblast. 
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INTRODUCTION 
The placenta, in part, serves as a semipermeable barrier separating the maternal 
and fetal circulations.  The placental barrier is comprised of a single layer of 
trophoblasts that have an important role in controlling the passage of molecules from 
mother to fetus.  In general, the absorption of drugs across the single layer of 
trophoblasts can be explained in terms of the pH-partition hypothesis which is well 
illustrated by passive diffusion mechanisms.1,2    However, with the use of brush-border-
membrane vesicle techniques or cultured cells3, it has become increasingly clear that 
there are a number of carrier-mediated transport mechanisms present at the placental 
barrier including systems for amino acids3,4, transferrin5, and dopamine6.   These 
carriers take on pharmaceutical relevance due to the fact that nutrients, hormones, as 
well as, drugs and drugs of abuse can be transported across the placental barrier by 
these mechanisms.7 
Carrier-mediated transport mechanisms for monocarboxylic acids exist in many 
cell types.8-10  In fact, there are known to be at least seven putative monocarboxylic acid 
transporter (MCT) isoforms.  The mRNA representing five of the seven MCTs has been 
shown in human placenta11.   Using brush border membrane preparations, a functional, 
proton-dependent MCT has been observed in tissues from rat12,13 and human14 
placenta.   A functional, bidirectional, and carrier-mediated mechanism for lactic acid, 
presumably a MCT, has also been demonstrated in the perfused human placental lobe 
model15.   In addition to the transport of lactic acid,11,14,15 a MCT at the placental barrier 
presents a potential mechanism by which monocarboxylic acid drugs and drugs of 
abuse may readily distribute between maternal and fetal compartments.  Therefore, the 
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characterization of a placental MCT system can contribute to an understanding of the 
trophoblast transport mechanisms controlling fetal exposure to substances possessing 
a monocarboxylic acid constituent.  
The objective of this study was to investigate the presence of a functional MCT in 
BeWo cell monolayers, a representative human trophoblast culture system.16  BeWo 
cell monolayers have been applied to studies of the polarized trans-trophoblast 
transport of serotonin and transferrin, monoamine uptake processes, and relevant 
nutrient uptake and transport systems.16-18   The existence of MCT systems in the BeWo 
cells would provide an in vitro tool representative of the human trophoblast to 
characterize trans-placental transport mechanisms that influence drug distribution in 
pregnancy.  The BeWo cell line is particularly attractive for the studies of drug 
distribution at the placenta barrier because it is stable, relatively easy to maintain by 
passage, and grows to a confluent monolayer in relatively short period of time. Indeed, 
in contrast to primary cultures, the cell line is one of the few existing trophoblast cell 
culture systems to form a confluent monolayer that allows trans-trophoblast transport 
studies.    More importantly, the BeWo cell displays morphological properties and 
biochemical marker enzymes and hormone secretion common to normal trophoblasts.16  
  
MATERIALS AND METHODS 
Materials.  [14C]Benzoic acid (55 Ci/mol), [14C]-L-lactic acid (150 Ci/mmol), and 
[14C]acetic acid (55 Ci/mol) were obtained from American Radiolabeled Chemicals (St. 
Louis, MO).  Fetal bovine serum (FBS) was from JRH Bioscience (Lenexa, KS).  
Penicillin-streptomycin as a mixture was from Gibco (Gaithersburg, MD).  Translucent 
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polycarbonate filters (13 mm diameter, 0.4 µm pore size) were purchased from Fisher 
Scientific.  All other chemicals were of the purest available analytical grade and 
purchased from Fisher or Sigma (St. Louis, MO). 
Cell Culture. The BeWo cell line was originally derived from a human 
choriocarcinoma.  The BeWo clone (b30) was obtained from Dr. Alan Schwartz 
(Washington University, St. Louis, MO).  The cells were cultured by the methods 
previously described and the cells used in these experiments  were from passages 28 
to 40.16.  Briefly, the cells were cultured in Dulbecco's modified Eagle's medium (DMEM) 
with 10% heat-inactivated FBS containing 0.37 % sodium bicarbonate and 1% 
antibiotics (10,000 U/ml penicillin and 10 mg/ml streptomycin).  The cells were 
maintained in 175-cm2 flasks at pH 7.4 under 5% CO2 and 95% humidity at 37°C.  The 
cells were harvested by exposure to a trypsin-EDTA solution (0.25% trypsin and 0.02% 
EDTA in HBSS) and passed onto 12-well tissue culture plates or polycarbonate 
membranes coated with rat tail collagen in 100-mm culture dishes.  With the seeding 
density of 10,000 cells/cm2, the cells formed confluent monolayers between 2 and 3 
days and were used for experiments at that time.  
Uptake Experiments. The BeWo cells at confluence were washed twice with 
Hank’s balanced salt solution (HBSS; 136.7 mM NaCl, 0.385 mM Na2HPO4, 0.441 mM 
KH2PO4, 0.952 mM CaCl2, 5.36 mM KCl, 0.812 mM MgSO4, 25 mM D-glucose and 10 
mM HEPES (2-[4-(2-Hydroxyethyl)-1-piperazinyl]ethanesulfonic acid) for adjustment to 
pH 7.0 or 7.5 or 10 mM MES (2-morpholinoethanesulfonic acid, monohydrate) for 
adjustment to pHs <6.5 and then the test solution containing [14C]benzoic acid or 
[14C]acetic acid or [14C]-L-lactic acid was added at 0.25 µCi/ml as a marker for 
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monocarboxylic acid carrier-mediated transport.  The pH of the test solution was 6.0 
except in the pH-dependent uptake experiments.  After 30 s, the test solution was 
aspirated away and the cells were washed with ice-cold HBSS three times.  For 
quantitation of drug uptake, the cells were suspended in 1.0 N NaOH and the 
suspension was incubated at 37°C overnight at which point, a half volume of 2.0 N HCl 
was added.  Radioactivity was quantitated using a liquid scintillation counter.  Cellular 
protein was quantified using a protein assay kit (Pierce) with bovine serum albumin as a 
standard.  Details of the conditions for each experiment are given in the Figure Legends 
or Table Footnotes. 
In one series of experiments, an equivalent amount of choline chloride replaced 
sodium chloride in the HBSS and was used as a sodium-depleted buffer.  
Transport Experiment.  A horizontal Side-Bi-Side diffusion apparatus (Crown 
Glass) was used to measure the transmonolayer permeability of cells grown on the 
surface of 0.4 µm pored polycarbonate filters, as previous described.16  The cells faced 
the donor chamber as the apical side, and the polycarbonate membrane faced the 
receiver chamber as the basolateral side.  The water jacket surrounding the donor and 
the receiver chambers was thermostated at 37°C.  The contents of each chamber were 
continuously stirred at 600 rpm with magnetic stir bars.  When the apical-to-basolateral 
transport studies were performed, the pH of the donor (apical) side was 6.0 and that of 
receptor (basolateral) side was 7.4.  When the basolateral-to-apical transport studies 
were performed, the pH of the donor (basolateral) side was 6.0 and that of receptor 
(apical) side was 7.4.  The concentration of added [14C]benzoic acid was 0.25 µCi/ml.  A 
0.2-ml aliquot from the receiver chamber was taken at several time points up to 60 min. 
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Calculation of Apparent Permeability Coefficients.  Apparent permeability 
coefficients for the monolayers of cells, Pe, were calculated from the following 
relationship 
1/Pt = 1/Pe + 1/Pm                                             Eq. (1)  
where Pt is apparent permeability coefficient for the collage-coated membrane in the 
presence of monolayers, and Pm is the apparent permeability coefficient for collagen-
coated polycarbonate membrane alone.19 
Michaelis-Menten Parameters. To estimate the values of the kinetic parameters 
of saturable uptake by BeWo cells, the uptake rate (J) was fitted to the following 
equation, which consists of both saturable and nonsaturable linear terms, using a 
nonlinear least-squares regression analysis program MULTI:20  
J = Jmax  X  C  /   ( Kt  +  C )  +  k  X  C               Eq. (2)    
where Jmax is the maximum uptake rate for a carrier-mediated process, C is the benzoic 
acid concentration, Kt is the half-saturation concentration (Michaelis constant), and k is 
a first-order rate constant.   
Statistical Analysis.  All results were expressed as means ± standard deviation 
(SD).  Statistical analysis between two groups was performed using Student's t-test, and 
one-way analysis of variance (ANOVA) was used for single and multiple comparisons.  
P values of 0.05 or less were considered to indicate a statistically significant difference.    
 
RESULTS 
[14C]Benzoic acid was rapidly accumulated in BeWo cells with time (Figure 1).  
The uptake was linear initially and reached equilibrium at about 2 min.  Therefore, all 
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subsequent uptake studies and kinetic analysis were performed from data collected 
through 30 s.   
Figure 2 shows the relationship between the initial rate of uptake of [14C]benzoic 
acid and its concentration in the incubation buffer.  The results indicated that the uptake 
of benzoic acid consisted of two processes, a saturable process evident at low 
concentrations and an apparently nonsaturable process evident at high concentrations.  
The uptake processes were analyzed according to Eq. (2).  The kinetic parameters 
calculated for benzoic acid uptake were a Jmax of 0.52 ± 0.22 nmol/30 s/mg of protein, a 
Kt of 0.64 ± 0.26 mM, and a k of 0.11 ± 0.06 µl/30 s/mg of protein.  The upper dotted 
line represents the uptake for the saturable component calculated from the kinetic 
parameters.  The lower dotted line represents the uptake for the nonsaturable 
component calculated from the kinetic parameters.  At any given concentration, the 
uptake by saturable component was higher than that by nonsaturable one. 
The effects of metabolic inhibitors on the uptake of [14C]benzoic acid were 
studied to determine whether this uptake required cell-dependent energy expenditure 
(Table 1).  Sodium azide (10 mM), a respiratory chain inhibitor, or 2,4-dinitrophenol (1 
mM), an uncoupler of oxidative phosphorylation, significantly inhibited the uptake of 
[14C]benzoic acid by the BeWo cells.  Moreover, carbonylcyanide p-
trifluoromethoxyphenylhydrazone (FCCP; 50 µM), a protonophore, significantly inhibited 
the uptake (Table 1), whereas 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS; 0.1 
mM), an anion-exchange inhibitor, had no inhibitory effect on benzoic acid uptake.   
Finally,  the uptake of benzoic acid in a sodium-depleted buffer was not different from 
the control suggesting the mechanism was not sodium-dependent (Table1).  Figure 3 
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illustrates the effect of incubation buffer pH in the range from 5.0 to 7.5 on [14C]benzoic 
acid uptake by BeWo cells.  The rate of [14C]benzoic acid uptake decreased with 
increasing pH from an acidic to a neutral pH.   These findings, together with the 
concentration dependence and sensitivity to metabolic inhibitors, strongly suggested 
that [14C]benzoic acid uptake by BeWo cells was dependent on a proton gradient and 
was carrier-mediated.     
To investigate the properties of the carrier involved in [14C]benzoic acid uptake by 
BeWo cells, we studied the effects of various mono- and di- carboxylic acids on this 
uptake (Table 2).  Each monocarboxylic acid, including lactic acid, significantly inhibited 
the uptake of [14C]benzoic acid, whereas none of the dicarboxylic acids had a significant 
inhibitory effect on the uptake of the marker.  We also found that the BeWo cells take up 
[14C]acetic acid and that this uptake was significantly inhibited by monocarboxylic acids, 
including lactic acid (Table 2).  In contrast, dicarboxylic acids had no marked effect on 
the uptake of [14C]acetic acid by BeWo cells.  These results implied that the carrier that 
mediates monocarboxylic acid uptake by BeWo cells was a nonspecific monocarboxylic 
acid carrier.   Additionally, the carrier is relatively stereoselective as distinguished by the 
variable inhibition by the two lactic acid isomers 
  To study the mechanism of the benzoic acid or acetic acid or lactic acid uptake 
inhibition by the monocarboxylic acids, we analyzed the inhibitory effect kinetically.  
Figure 4A shows a Lineweaver-Burk plot for the uptake of [14C]benzoic acid by BeWo 
cells in the absence or presence of 2 mM acetic acid.  Acetic acid competitively inhibited 
the uptake of benzoic acid by the BeWo cells.  Figure 4B shows a Lineweaver-Burk plot 
for the uptake of [14C]acetic acid by BeWo cells in the absence or presence of 2 mM 
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benzoic acid.    Similarly, Figures 4C and 4D confirm that lactic acid and benzoic acid 
interact with the BeWo uptake mechanism by a competitive process.   Table 3 
summarizes the kinetic data and indicates that the Km’s and Ki’s for benzoic, acetic, and 
lactic acid for the apparent moncarboxylic acid uptake mechanism were similar.   
The trans-trophoblast passage of [14C]benzoic acid across the BeWo monolayer 
was found to be asymmetric, with the permeability coefficient greater in the apical-to-
basolateral direction than that in the basolateral-to-apical direction, as shown in Table 4.  
The passage of [14C]benzoic acid across the BeWo monolayers was inhibited by an 
excess amount of unlabeled benzoic acid or other monocarboxylic acid (valproic acid) 
as shown in Table 4, affirming that the transcellular passage of the monocarboxylic acid 
appeared similar to the uptake process. 
     
DISCUSSION   
Passive diffusion is the primary mechanism by which xenobiotics cross the 
placental barrier.1   However, some carrier-mediated transport systems in the 
trophoblast have been described using brush-border membrane vesicles or cultured 
cells,3,5,6 including functional MCTs.12-14   These carrier systems are notable for 
mediating the distribution of both endogenous and exogenous substances across the 
placental barrier.7  Recent studies in knockout mice have effectively illustrated the 
relevance of placental transport mechanisms, e.g., P-glycoprotein, in protecting the 
fetus from exposure to chemicals.21   Consequently, the recognition of  transport 
mechanisms is important for developing an understanding of the molecular mechanisms 
and role of the trophoblast in regulating drug passage across the placental barrier.   
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There is also a critical need for in vitro systems of human origin that allow 
characterization of mechanisms regulating drug distribution between mother and fetus 
to aid in the future design and development of drugs that can be safely administered in 
pregnancy.22,23    
In the present study, we used benzoic acid uptake and transport, as a marker for 
the monocarboxlic acid transport8 in BeWo cell monolayers.  The establishment of 
functional MCT mechanisms in the BeWo cells offers the opportunity to characterize 
mechanisms of monocarboxylic acid transport at the molecular and biochemical level, 
extending limited studies performed with brush border preparations12-14 and the 
perfused human placental lobe.15   
The processing of benzoic acid by the BeWo monolayers was characterized by 
saturable uptake and transport.  The processes were significantly inhibited by metabolic 
inhibitors and indicated that benzoic acid uptake is energy dependent.  Benzoic acid 
transport and uptake were also significantly inhibited by in a competitive manner by 
unlabeled benzoic acid, acetic acid, and lactic acid.  Further, benzoic acid uptake and 
transport were significantly inhibited by monocarboxylic acids but not selected 
dicarboxylic acids.  The competitive nature of the transport, evidenced by the kinetic 
parameters, was consistent with observations reported for the transport of 
monocarboxylic acids in placental brush border vesicles.12-14    
The advantage of the BeWo monolayer system is that trans-trophoblast transport 
properties can be characterized in a polarized cell.16   We were able to show the 
passage of benzoic acid across the BeWo monolayers was bidirectional and of a faster 
rate going in the apical-to-basolateral side direction across the monolayers in the 
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presence of a pH gradient.   These observations are in good agreement with the lactate 
transport studies performed in the perfused human placental lobe model.15  Further, our 
studies suggested a functional asymmetry in the carrier mechanism.  
 Caco-2 cells, which are a well-characterized model of the intestinal epithelium, 
possess a monocarboxylic acid transport system which is pH dependent.8  The 
activation of benzoic acid uptake by acidic pH can be explained by H+ cotransport, OH- 
exchange system, or a possible change in affinity to the carrier protein depending on 
the extracellular pH.  The uptake of benzoic acid by BeWo monolayers increased with a 
decreased pH.   The lack of an inhibitory effect of DIDS, an inhibitor of anion exchange, 
suggests that an OH- exchange system with benzoic acid was not involved in uptake or  
transport  by BeWo cells.  Many types of transporters are Na+ dependent.  However, 
benzoic acid uptake by BeWo cells was also not inhibited in the Na+-depleted buffer in 
this study. Benzoic acid is an acidic compound; therefore, a decrease in pH increases 
the fraction of nonionized benzoic acid.  According to the pH-partition hypothesis, this 
increase in the fraction of nonionized form increases the passive accumulation of 
benzoic acid across the BeWo cell membrane.   Data presented here (e.g., Figure 3), 
and other studies conducted in absence of pH gradients, where the rate of transfer and 
asymmetry of transport for representative monocarboxylic acid drugs (e.g, 
acetylsalicylic acid and ibuprofen) is substantially diminished (data not shown), are 
alone insufficient to conclude that the uptake of benzoic acid is proton-gradient-
dependent.  However, the need for a proton gradient was affirmed with our results that 
showed FCCP, a protonophore, strongly inhibited the uptake of benzoic acid.    
Collectively then, our results indicated that monocarboxylic acid uptake was proton-
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gradient-dependent and were entirely consistent with similar studies conducted with 
human trophoblast brush border membrane preparations.14   From a pharmacological 
and physiological perspective, this is significant since a pH gradient does develop 
across the placenta with advancing pregnancy.    The developing pH gradient does 
influence drug distribution across the placenta24 and may possibly influence the MCT 
carrier’s role in regulating the distribution of monocarboxylic acids between the mother 
and fetus. The physiological role of a MCT in the trophoblast is likely related to the 
regulation of the distribution of L-lactic acid and related substrates across the placental 
barrier.14,15 
Monocarboxylic acids are transported out of muscle and into liver (i.e., the so-
called Cori cycle) by proton-coupled transporters, MCTs, that exhibited distinct 
substrate specificities and could be differentially inhibited by α-cyanocinnamates.  
MCT1 isolated from a Chinese hamster ovary cell cDNA library, is found in cardiac 
muscle, erythrocytes, basolateral intestinal epithelium, and skeletal muscle.  MCT2, 
cloned from hamster liver, is functionally similar to MCT1 in terms of transport 
capabilities, but its tissue distribution is significantly different.25   A third transporter 
isoform, MCT3, was identified in chick retinal pigment epithelium.  More recently, four 
new MCT homologs have been cloned and sequenced in human tissue (MCT3-
MCT7).11   There is currently no direct information of the type of functional MCTs 
associated with BeWo cells or human trophoblasts.  Thus, further studies with molecular 
probes and selective substrates, when available, will be required to precisely identify 
which of the seven monocarboxylic acid transporter isoforms may be present in the 
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human placental barrier.   Elucidating the precise forms of functional MCTs in the 
trophoblast remains an ongoing objective of our laboratory. 
In summary, our present results support limited evidence in the literature12-15 that 
monocarboxylic acids and nutrients, drugs, drugs of abuse and other xenobiotics that 
have a monocarboxylic acid constituent have the potential to be substrates for proton-
gradient-dependent transport  across the human trophoblast.  This work further 
demonstrates the possible utility of a human, monolayer-forming cell line, BeWo, to 
characterize putative trans-trophoblast transport mechanisms and their potential roles in 
controlling nutrients, drugs, and drugs of abuse distribution across the placental barrier. 
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Figure Legends 
 
Figure 1. Time course of [14C]benzoic acid uptake by BeWo cells.  The vertical bar 
through each point represents the SD for four replicate experiments.   
 
 
Figure 2.  Concentration dependency of [14C]benzoic acid uptake by BeWo cells.  The 
uptake of [14C]benzoic acid by BeWo cells was measured at 37ºC for 30 s.  The upper 
dotted line represents the uptake for the saturable component calculated from the 
kinetic parameters obtained as described in the text.  The lower dotted line represents 
the uptake for the nonsaturable component calculated from the kinetic parameters.   
The vertical bar through each point represents the SD of four replicate experiments.   
 
 
Figure 3.  pH dependence of [14C]benzoic acid uptake by BeWo cells.  The uptake of 
[14C]benzoic acid by BeWo cells was determined at the indicated pH at 37ºC.  The 
vertical bar through each point represents the SD of four replicate experiments.   
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Figure 4.  Lineweaver-Burk plots for:  A) The concentration-dependent uptake of 
[14C]benzoic acid by BeWo cells.  Uptake was measured in the absence (open circles) 
or presence of 2 mM acetic acid (closed circles).  B) The concentration-dependent 
uptake of [14C]acetic acid by BeWo cells.  Uptake was measured in the absence (open 
triangles) or presence of 2 mM benzoic acid (closed triangles).  C) The concentration-
dependent uptake of [14C]-L-lactic acid by BeWo cells.  Uptake was measured in the 
absence (open circles) or presence of 2 mM benzoic acid (closed circles).  D) The 
concentration-dependent uptake of [14C]benzoic acid by BeWo cells.  Uptake was 
measured in the absence (open circles) or presence of 2 mM L-lactic acid (closed 
circles).   The vertical bar through each data point in the figures represents the SD of 
four replicate experiments. 
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Table 1.  Effects of metabolic inhibitors, ionophore (carbonylcyanide p-
trifluoromethoxyphenylhydrazone; FCCP), anion-exchange (4,4'-
diisothiocyanostilbene-2,2'-disulfonic acid; DIDS) inhibitors, and sodium-depleted 
buffer on [14C] benzoic acid uptake by BeWo cell monolayers at 37°C.a 
 
Inhibitor 
 
Concentration 
Relative Uptake 
(Percent of Control)b 
Sodium azide 10 mM 20.1  ±  5.2 * 
2,4-Dinitrophenol 1 mM 13.3  ±  7.4 * 
FCCP 50 µM  9.3   ±  1.4 * 
DIDS 100 µM 117.5 ±   8.1   
Sodium-depleted buffer No treatment 101.7 ± 11.7 
a   BeWo cells were pretreated with these agents for 15 min prior to performing an 
uptake experiment. 
b Each value represents the mean ± standard deviation of four experiments. 
* P < 0.001 versus untreated control (100%).  
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Table 2.  Effects of selected carboxylic acids on [14C]benzoic acid or [14C]acetic 
acid uptake by BeWo cell monolayers at 37°C.a 
  Relative uptake  
(Percent of control)b 
  [14C]benzoic acid [14C]acetic acid 
Monocarboxylic acids Benzoic acid 10.8 ± 0.2* 19.5 ± 2.7* 
 D-Lactic acid 20.4 ± 1.8*  26.5 ± 4.2* 
 L-Lactic acid    6.1 ± 1.3* 13.4 ± 1.5* 
 Propionic acid 12.7 ± 0.9* 18.9 ± 2.6* 
 Acetic acid 10.1 ± 2.0* 36.9 ± 2.9* 
 p-Aminobenzoic acid   5.5 ± 0.1* 20.7 ± 3.4* 
 Acetylsalicylic acid 12.3 ± 1.3* 11.1 ± 1.0* 
 Salicylic acid   3.5 ± 0.1*    9.3 ± 0.7* 
    
Dicarboxylic acids Glutaric acid   91.0 ± 8.5 107.2 ±12.8 
 Fumaric acid 113.8 ± 5.5    98.4 ±10.4 
 Maleic acid   92.1 ± 7.3 102.4 ±28.4 
a [14C]benzoic acid or [14C]acetic acid uptake by BeWo cells were performed in the 
presence of 10 mM (2000-fold excess) of the indicated carboxylic acid.  
b Each value represents the mean ± standard deviation of four experiments. 
* P < 0.001 versus untreated control (100%).  
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Table 3.  Lineweaver-Burke uptake and inhibition constants for monocarboxylic 
acid uptake by BeWo cell monolayers at 37°C. 
  Benzoic acid Acetic Acid Lactic Acid 
 Km (mM)b Ki (mM) b Ki (mM) b Ki (mM) b 
[14C]Benzoic acida 1.0 ± 0.1 - 1.1 ± 0.2 0.7 ± 0.3 
[14C]Acetic acida 0.8 ± 0.2 0.8 ± 0.3 - - 
[14C]Lactic acida 1.4 ± 0.2 0.7 ± 0.2 - - 
a [14C]benzoic acid or [14C]acetic acid or [14C]lactic acid uptake by BeWo cells were 
performed alone and in the presence of 2 mM (1 to 8-fold excess) of the indicated 
monocarboxylic acid.  
b Each value represents the mean ± standard deviation of four experiments. 
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Table 4.  Apparent permeability coefficients for the passage of  [14C]benzoic acid 
across BeWo cell monolayers at 37°C. 
Direction of benzoic acid 
permeation across monolayer 
 
Treatment 
Permeability Coefficient 
(x 103 cm/sec) 
Apical to basolateral none 4.90 ± 1.01 
 + benzoic acida 0.45 ± 0.04* 
 + valproic acida 0.64 ± 0.21* 
Basolateral to apical  none 1.06 ± 0.70* 
a [14C]benzoic acid permeation across BeWo cell monolayers was performed in the 
presence of 10 mM (2000-fold excess) of the indicated carboxylic acid in the 
apical chamber.  
* P < 0.001 versus untreated benzoic acid permeation apical to basolateral. 
 
